Rayner
Claire Rendell (FCIPD) has had extensive work experience in the field of human resources. Claire started their career at Tui Travel PLC in 2009, where they worked as an HR Business Partner until 2011. Claire then joined CR Bard as an HR Director, first for North Europe and later for Eastern Europe, the Middle East, and Africa.
In 2018, Claire moved to Edwards Vacuum as an HR Business Partner for the EMEA region. After a year, they transitioned to Acro Aircraft Seating as the HR Director. Claire'smost recent position was at Rayner, where they initially served as the Human Resources Director before being promoted to Vice President of Human Resources.
Claire has demonstrated expertise in various HR roles and has effectively managed HR functions in global organizations.
Claire Rendell (FCIPD) has a history of education that includes attending CIPD. The specific degree or field of study is not provided. Additionally, Claire has obtained additional certifications including an Insights Discovery Accreditation from Insights and a Mental Health First Aider certification from Mental Health First Aid (MHFA) England. No specific dates of obtaining these certifications are mentioned.
This person is not in any offices
Rayner
5 followers
Rayner designs and manufactures intraocular lenses and proprietary injection devices for use in cataract surgery. When Sir Harold Ridley designed the world’s first IOL in 1949, he chose Rayner to manufacture this ground-breaking invention.With more than 65 years of continuous growth and experience, we remain at the forefront of innovation. Weare focused on providing the best IOLs for clinicians and patients and are driven by science to improve patient outcomes and safety.Primary IOLs Our FDA-approved C-flex aspheric (aberration-neutral) monofocal IOL, as well as our toric and multifocal IOL families are now complemented by the RayOne fully preloaded monofocal IOL injection system. Supplementary IOLsDesigned to be implanted in the ciliary sulcus, Rayner Sulcoflex Pseudophakic Supplementary IOLs are available as aspheric, toric, multifocal and multifocal lenses, and offer a reversible solution for correcting residual post-operative refractive errors following the implantation of a conventional IOL in the capsular bag.OVDsOur Ophteis range offers a full spectrum of OVDs from dispersive to cohesive, enabling surgeons to select the OVD best suited to each specific cataract procedure. Ophteis FR Pro with sorbitol -- designed to deliver a new level of corneal endothelial protection from phaco induced trauma -- is the flagship product of Rayner’s ‘Ophteis’ OVD suite. PharmaceuticalsAlthough the intraocular lens plays a leading role in the visual outcomes of cataract and refractive surgery, the pharmaceuticals that manage the tear film and inflammation are critical to the end result. For that reason, Rayner recently acquired the business of Moorfields Pharmaceuticals. The acquisition will enable us to offer an even wider range of ophthalmic tools that aid and streamline the surgical process whilst remaining focused on the visual outcome for the patient.Rayner markets its IOL portfolio and related products worldwide through a network of distributors in over 80 countries with direct markets in UK, Germany & Austria, the United States of America, Italy and Spain. We have the world’s longest commercial history of IOL design and manufacturing and have worked with cataract surgeons for longer than anyone else.In 2016, Rayner transferred its global headquarters to a brand new state of the art manufacturing plant, which has dramatically increased the company’s production capacity.